chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: Sore arm; significant body aches; headache; nausea; fatigue; low grade fever; This is a spontaneous report from a contactable other healthcare professional. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date and unknown if its ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 19:00, the patient experienced sore arm, significant body aches, headache, nausea, fatigue, low grade fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event sore arm, significant body aches, headache, nausea, fatigue and low grade fever were recovering. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 11Apr2021 at 14:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore arm; significant body aches; headache; nausea; fatigue; low grade fever; This is a spontaneous report from a contactable other healthcare professional. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date and unknown if its ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 19:00, the patient experienced sore arm, significant body aches, headache, nausea, fatigue, low grade fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event sore arm, significant body aches, headache, nausea, fatigue and low grade fever were recovering. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 11Apr2021 at 14:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Pruritus, Rash, Swelling
Clinical narrative: Inflamed; Red; Became itchy/ faint itchiness; seemed like a rash  at this point; seemed like a hives at this point; Have developed small bumps all over forearms the next day after the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 20:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia and allergic to cats. Patient had a repeating history of anemia which was not too serious and if it gets low, she was prescribed medication. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and ferrous sulfate (IRON) all for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other medications within four weeks prior to the COVID-19 vaccine. On 10Apr2021 the next day after the vaccine, the patient experienced small bumps all over forearms . On 11Apr2021 two days after the vaccine, the small bumps became red, itchy and inflamed which seemed like a rash or hives at that point. Three days after the vaccine patient still had faint itchiness in it which had not spread nor had they gone away or showed signs of going away. Therapeutic measures were not taken as a result of the events.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events small bumps all over forearms, red, itchy and inflamed which seemed like a rash or hives at that point and faint itchiness was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Inflamed; Red; Became itchy/ faint itchiness; seemed like a rash  at this point; seemed like a hives at this point; Have developed small bumps all over forearms the next day after the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 20:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia and allergic to cats. Patient had a repeating history of anemia which was not too serious and if it gets low, she was prescribed medication. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and ferrous sulfate (IRON) all for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other medications within four weeks prior to the COVID-19 vaccine. On 10Apr2021 the next day after the vaccine, the patient experienced small bumps all over forearms . On 11Apr2021 two days after the vaccine, the small bumps became red, itchy and inflamed which seemed like a rash or hives at that point. Three days after the vaccine patient still had faint itchiness in it which had not spread nor had they gone away or showed signs of going away. Therapeutic measures were not taken as a result of the events.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events small bumps all over forearms, red, itchy and inflamed which seemed like a rash or hives at that point and faint itchiness was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Diarrhoea, Pain
Clinical narrative: Low grade fever (100.6); Chills; Aches; Stomach discomfort; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 02Apr2021 at 16:30 (at the age of 77-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), clopidogrel bisulfate (PLAVIX), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 12:00, the patient experienced low grade fever (100.6), chills, aches, stomach discomfort and diarrhea. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 10Apr2021, the patient underwent body temperature test and the result was 100.6 (unspecified units). The clinical outcome of the events low grade fever (100.6), chills, aches, stomach discomfort and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Low grade fever (100.6); Chills; Aches; Stomach discomfort; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 02Apr2021 at 16:30 (at the age of 77-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), clopidogrel bisulfate (PLAVIX), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 12:00, the patient experienced low grade fever (100.6), chills, aches, stomach discomfort and diarrhea. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 10Apr2021, the patient underwent body temperature test and the result was 100.6 (unspecified units). The clinical outcome of the events low grade fever (100.6), chills, aches, stomach discomfort and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dissociation, SARS-CoV-2 test, Vertigo
Clinical narrative: Abrupt onset of vertigo; Some element of confusion; "Felt a weird sense of disassociation with this around"; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Mar2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included biotin (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), spironolactone (ALDACTONE) and cannabidiol (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 07Apr2021, the patient underwent lab tests and procedures which included nasal swab test and the result was negative. On 11Apr2021 at 08:00, the patient experienced abrupt onset of vertigo, some element of confusion and felt a weird sense of disassociation with this around her. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event abrupt onset of vertigo, some element of confusion and "Felt a weird sense of disassociation with this around" was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Fast heart beat; Tiredness; joint pain; Chills; Headache; Muscle pain; High fevers; couldnt stop sweating.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 00:00, the patient experienced fast heartbeat, tiredness, joint pain, chills, headache, muscle pain and patient was under 3 blankets for 2 days and could not stop sweating, high fevers and could not go to work on Monday. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the events fast heart beat tiredness, joint pain, chills, headache, muscle pain and could not stop sweating, high fever was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Tachycardia
Clinical narrative: Fast heart beat; Tiredness; joint pain; Chills; Headache; Muscle pain; High fevers; couldnt stop sweating.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 00:00, the patient experienced fast heartbeat, tiredness, joint pain, chills, headache, muscle pain and patient was under 3 blankets for 2 days and could not stop sweating, high fevers and could not go to work on Monday. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the events fast heart beat tiredness, joint pain, chills, headache, muscle pain and could not stop sweating, high fever was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Flatulence, Gastrointestinal pain
Clinical narrative: Slight chills; Joint pain; Gastrointestinal gas; Gastrointestinal cramps; Looser stool; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 09Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included alfuzosin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 18:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 12:00, the patient experienced slight chills, joint pain, gastrointestinal gas/cramps and looser stools. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event's slight chills, joint pain, gastrointestinal gas/cramps and looser stools was unknown at the time of this report.    No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Pain in extremity, Rash, Rash macular
Clinical narrative: Weakness; pain in left armfrom scapula down left arm. Extremelypainful to touch and move.; 3 days agonoted multiple red spots on left hand(palm sized) that is painful to touch.; Rash seems to be spreading.; 3 days agonoted multiple red spots on left hand(palm sized) that is painful to touch.; Extremely painful to touch and move.; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GP7534) via an unspecified route of administration in the left arm on 21Mar2021 at 12:30 as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 28Feb2021 at 12:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021, the patient experienced weakness and pain in left arm from scapula down left arm and extremely painful to touch and move and three days ago noted multiple red spots on left hand (palm sized) that is painful to touch and rash seems to be spreading. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events weakness, pain in arm, red spotty rash, painful rash, extremely painful to touch and move and spreading rash were ongoing at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Paraesthesia, Pyrexia
Clinical narrative: soreness at the injection site; low grade fever; chills; slight headache; fatigue; tingle radiate from the injection site to my finger tips; left hand when held outward was trembling which was the side my injection was given. When I placed both my hands in front of me I visibly see my left hand fingers were trembling but not my right hand.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 14Apr2021 after injection, the patient experienced tingle radiating from the injection site to finger tips. On 14Apr2021 at 17:15, two hours after the injection, the patient experienced left hand when held outward was trembling, when placed both hands in front she could visibly see left hand fingers were trembling but not right hand. The patient also experienced soreness at the injection site, low grade fever, chills, fatigue and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingle radiates from the injection site to finger tips, left hand when held outward was trembling, soreness at the injection site, low grade fever, chills, fatigue and slight headache was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination site pain
Clinical narrative: soreness at the injection site; low grade fever; chills; slight headache; fatigue; tingle radiate from the injection site to my finger tips; left hand when held outward was trembling which was the side my injection was given. When I placed both my hands in front of me I visibly see my left hand fingers were trembling but not my right hand.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 14Apr2021 after injection, the patient experienced tingle radiating from the injection site to finger tips. On 14Apr2021 at 17:15, two hours after the injection, the patient experienced left hand when held outward was trembling, when placed both hands in front she could visibly see left hand fingers were trembling but not right hand. The patient also experienced soreness at the injection site, low grade fever, chills, fatigue and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingle radiates from the injection site to finger tips, left hand when held outward was trembling, soreness at the injection site, low grade fever, chills, fatigue and slight headache was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: The day after the vaccine, about 24 h following injection, noticed small tender bruises on both my legs, about 4 or 5 bruises per leg, w no trauma or cause. No Hx of similar past issues.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 12Apr2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, spondylarthritis, eczema and tachycardia. Concomitant medications included hydroxyzine (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), loloestrine (MANUFACTURER UNKNOWN) and semaglutide (OZEMPIC), all were from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 17Mar2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 22:00, the patient noticed small tender bruises on both of her legs, about 4 or 5 bruises per leg, with no trauma or cause, a day after the vaccine, about 24 h following the injection and no Hx of similar past issues. The events did not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event bruise was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Random single itchy hives that come and go within a few hours on different areas of the body; This is a spontaneous report from a contactable other healthcare professional. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2813) via intramuscular route of administration in the left arm on 19Mar2021 at 15:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had pollen allergy and had no other medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021, on day 3 after first vaccine, the patient experienced random single itchy hives that came and went within a few hours on different areas of the body and was lasting for about a week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken for the event. The clinical outcome of the event random single itchy hives that come and go within a few hours on different areas of the body was unknown at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via intramuscular route of administration in the left arm on 09Apr2021 at 16:15 as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Nausea, Pain
Clinical narrative: Woke up and felt very naseaus; vomited; fatigued; chills; body aches for the rest of the day; felt very weak; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 09:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included depression. Patient had no known allergies to food, medications and other products. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN) and cannabis sativa (CANNABIS) both for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 06:45 when the patient woke up, she felt very nauseous. After an hour, vomited and felt very weak, fatigued, and had chills and body aches for the rest of the day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches for the rest of the day, felt very weak, very nauseous, vomited, fatigued and chills were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Woke up and felt very naseaus; vomited; fatigued; chills; body aches for the rest of the day; felt very weak; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 09:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included depression. Patient had no known allergies to food, medications and other products. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN) and cannabis sativa (CANNABIS) both for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 06:45 when the patient woke up, she felt very nauseous. After an hour, vomited and felt very weak, fatigued, and had chills and body aches for the rest of the day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches for the rest of the day, felt very weak, very nauseous, vomited, fatigued and chills were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Maternal exposure during breast feeding
Clinical narrative: I am breastfeeding and my daughter developed a mild on her cheeks.; I am breastfeeding and my daughter developed a mild on her cheeks.; This is a spontaneous report from a contactable consumer. This consumer (mother) reported for a female patient (daughter).  This is the baby case report. A female patient of an unspecified age (child) received bnt162b2 (BNT162B2, formulation; Solution for injection Lot Ew0153),  via transmammary, on 10Apr2021 at 14.00, as an unspecified dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. on 11Apr2021, it was reported that mother was breastfeeding to her daughter and developed a mild on her daughter cheeks. The outcome of events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021401593 mother case
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling cold, Headache, Musculoskeletal stiffness
Clinical narrative: Nausea; Headache; Stiff arm and neck; Almost fainting; Dizziness; Cold achy; Cold achy; Tired; This is a spontaneous report from a contactable consumer (patient). This 42-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration on 30Mar2021 at 11:00 (at the age of 42-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included one kidney, lost left kidney to cancer, mitral valve prolapse, and left ventricle blockage in heart. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included ibuprofen (ADVIL) from an unknown date for an unknown indication. The patient previously received tetracycline from an unknown date and experienced allergy. The patient previously received dose 1 of BNT162B2 (lot number EN6204) on 19Mar2021 at 12:00 as a single dose in the right arm for COVID-19 immunization and experienced arm and neck pain instantly, fever, chills, and nausea. After the second dose of BNT162B2 on day 1 (30Mar2021) the patient experienced tired. On day 2 (31Mar2021) the patient was cold and achy. On day 3 (01Apr2021) the patient experienced stiff arm and neck. On day 4 (02Apr2021) the patient experienced nausea and headache. Two weeks later the patient had dizziness, almost fainting, and continued dizziness. The events were reported as non-serious. The patient was not hospitalized for the events. It was unknown if the patient received any treatment for the events. The outcomes of tired, cold, achy, stiff arm and neck, nausea, headache, dizziness, and almost fainting were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021403996 same patient, different drug(dose)/events
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Syncope
Clinical narrative: Nausea; Headache; Stiff arm and neck; Almost fainting; Dizziness; Cold achy; Cold achy; Tired; This is a spontaneous report from a contactable consumer (patient). This 42-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration on 30Mar2021 at 11:00 (at the age of 42-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included one kidney, lost left kidney to cancer, mitral valve prolapse, and left ventricle blockage in heart. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included ibuprofen (ADVIL) from an unknown date for an unknown indication. The patient previously received tetracycline from an unknown date and experienced allergy. The patient previously received dose 1 of BNT162B2 (lot number EN6204) on 19Mar2021 at 12:00 as a single dose in the right arm for COVID-19 immunization and experienced arm and neck pain instantly, fever, chills, and nausea. After the second dose of BNT162B2 on day 1 (30Mar2021) the patient experienced tired. On day 2 (31Mar2021) the patient was cold and achy. On day 3 (01Apr2021) the patient experienced stiff arm and neck. On day 4 (02Apr2021) the patient experienced nausea and headache. Two weeks later the patient had dizziness, almost fainting, and continued dizziness. The events were reported as non-serious. The patient was not hospitalized for the events. It was unknown if the patient received any treatment for the events. The outcomes of tired, cold, achy, stiff arm and neck, nausea, headache, dizziness, and almost fainting were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021403996 same patient, different drug(dose)/events
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Herpes zoster
Clinical narrative: Developed Shingles( left upper leg).; Also terrible joint pain. Had to get steroid shot for pain.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 08:15 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included immune system issues (not specified), psoriasis, arthritis and penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 02:00, the patient developed shingles (left upper leg), also terrible joint pain. The patient had to get steroid shot for pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with steroid shot for joint pain, and medication (not specified) for shingles. The clinical outcome of the event shingles (left upper leg) and terrible joint pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Gingival blister, Gingival injury
Clinical narrative: Blisters/cuts on gums; Blisters/cuts on gums; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to medications, food, or other products. Concomitant medication included fluticasone (FLUTICASONE NASAL SPRAY). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced blisters/cuts on gums. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event blisters/cuts on gums was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food or other products. Concomitant medications included vitamin d nos (VITAMIN D), sea essentials supplements (unspecified) and ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient experienced ringing in ears. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ringing in ears was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Rash morbilliform, Urticaria
Clinical narrative: Extreme hives; measle like reactions; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 11:45 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had no known allergies to medications, food, or other products. Concomitant medications included cholesterol 40 milligrams (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 03Apr2021 at 11:45, the patient experienced extreme hives, measles like reactions all over body especially trunk back, under arms forearms, wrists fingers and ankles. Since the vaccination, the patient had not been tested for COVID-19. The adverse events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. The clinical outcome of the events extreme hives and measles like reactions all over body especially trunk back, under arms forearms, wrists fingers and ankles was not recovered at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Gait inability, General physical health deterioration
Clinical narrative: Slept for 4 hours after shot; Lost ability to walk up stairs normally; Had to two step with cane; Ruined health; Blurred vision; Growths that had gone away are starting again on back; Occasional chills; Joints are all aching; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 73-year-old), as a single dose for COVID-19 immunisation. Medical history included had to two-step with cane and growths (not specified) on back. The patient had a history of allergy to latex. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 17Mar2021 at 13:00, the patient slept for 4 hours after the shot which had not done that before, extreme fatigue(still had), joints were all aching and lost ability to walk upstairs normally, blurred vision about an hour and the growths that had gone away started again on back and had occasional chills. The patient had to two step with cane and had gotten past that until shot ruined his health and the patient was very healthy before shot. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event slept after shot was recovered on 17Mar2021 at 17:00 after a duration of 4 hours, the event blurred vision was recovered on 17Mar2021 at 14:00 after a duration of 1 hour. The clinical outcome of events extreme fatigue, joints were all aching, lost ability to walk up-stairs normally, had to two-step with cane, ruined health, growths that had gone away started again on back, occasional chills and was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder, Somnolence, Vision blurred, Walking aid user
Clinical narrative: Slept for 4 hours after shot; Lost ability to walk up stairs normally; Had to two step with cane; Ruined health; Blurred vision; Growths that had gone away are starting again on back; Occasional chills; Joints are all aching; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 73-year-old), as a single dose for COVID-19 immunisation. Medical history included had to two-step with cane and growths (not specified) on back. The patient had a history of allergy to latex. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 17Mar2021 at 13:00, the patient slept for 4 hours after the shot which had not done that before, extreme fatigue(still had), joints were all aching and lost ability to walk upstairs normally, blurred vision about an hour and the growths that had gone away started again on back and had occasional chills. The patient had to two step with cane and had gotten past that until shot ruined his health and the patient was very healthy before shot. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event slept after shot was recovered on 17Mar2021 at 17:00 after a duration of 4 hours, the event blurred vision was recovered on 17Mar2021 at 14:00 after a duration of 1 hour. The clinical outcome of events extreme fatigue, joints were all aching, lost ability to walk up-stairs normally, had to two-step with cane, ruined health, growths that had gone away started again on back, occasional chills and was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.